A Phase I Study of BMS-275183 Given on a Daily Schedule in Patients With Advanced Malignancies
Clinical trial NCT00207025 · TERMINATED
Trial details
- NCT number
- NCT00207025
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2004-10-01
- Primary completion
- 2007-02-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.